Английская Википедия:Elezanumab

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Orphan Шаблон:Infobox drug Elezanumab (development names AE12-1Y-QL and ABT-555) is a fully human monoclonal antibody developed by AbbVie against repulsive guidance molecule A (RGMa). It has been tested in people with multiple sclerosis and acute ischemic stroke.[1][2][3][4]

References

Шаблон:Reflist